Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Details of Astrazeneca's U.S. FDA Inspections. Original Data: FDA Inspection Database

AstraZeneca
Neogene
Icosavax
CinCor Pharma
Acerta Pharma
Alexion Pharmaceuticals
FDA

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

AstraZeneca

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 5792 NEWS #PharmaBuzz

INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
5792 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

50 All APIs, 37 USDMF, 1 CEP/COS, 12 JDMF, 1 EU WC, 13 KDMF, 11 NDC API, 3 VMF, 1 Listed APIs

50 All APIs
37 USDMF
1 CEP/COS
12 JDMF
1 EU WC
13 KDMF
11 NDC API
3 VMF
1 Listed APIs

DEVELOPMENTS

690 Drugs in Development

690 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1280 FDF Dossiers, 206 FDA Orange Book, 661 Europe, 89 Canada, 164 Australia, 160 South Africa

1280 FDF Dossiers
206 FDA Orange Book
661 Europe
89 Canada
164 Australia
160 South Africa

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

23 FDA, 6 EDQM, 2 GDUFA

23 FDA
6 EDQM
2 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Legal Name Reset all filters

23 All

01 1Alexion Pharmaceuticals, Inc.

02 1Alexion Pharmceuticals, Inc.

03 6AstraZeneca AB

04 4AstraZeneca LP

05 1AstraZeneca UK Ltd.

06 6IPR Pharmaceuticals, Inc.

07 2MedImmune LLC

08 1MedImmune UK Limited

09 1Medimmune LLC

filter District Decision Reset all filters

23 All

01 15No Action Indicated

02 8Voluntary Action Indicated

filter Inspection End Date Reset all filters

23 All

01 12017-07-21

02 12017-04-25

03 12017-04-13

04 12017-02-17

05 12017-02-07

06 12017-01-27

07 12015-08-26

08 12014-09-26

09 12014-07-23

10 12013-07-29

11 12013-03-20

12 12012-09-21

13 12012-06-14

14 12012-05-29

15 12011-04-27

16 12010-12-09

17 12010-12-07

18 12010-05-17

19 12010-03-19

20 12009-12-21

21 12009-06-18

22 22008-10-08

filter City Reset all filters

23 All

01 6Canovanas

02 2Frederick

03 1Gaithersburg

04 1Holden

05 1Liverpool

06 1Macclesfield

07 1Smithfield

08 6Sodertalje

09 4Westborough

filter Country/Area Reset all filters

23 All

01 2GB

02 6SE

03 15US

FDA
EDQM
GDUFA

Supplier Virtual Booth

price-trend

01

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-05-17

AstraZeneca

City : Westborough

State : MA

Country/Area : US

Zip : 01581-3323

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-05-17

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

02

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-04-27

AstraZeneca

City : Westborough

State : MA

Country/Area : US

Zip : 01581-3323

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2011-04-27

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

03

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2012-06-14

AstraZeneca

City : Westborough

State : MA

Country/Area : US

Zip : 01581-3323

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2012-06-14

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

04

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2014-07-23

AstraZeneca

City : Westborough

State : MA

Country/Area : US

Zip : 01581-3323

District : NWE

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2014-07-23

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

05

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2010-03-19

AstraZeneca

City : Sodertalje

State :

Country/Area : SE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2010-03-19

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

06

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2010-12-09

AstraZeneca

City : Sodertalje

State :

Country/Area : SE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2010-12-09

Product
Web Link

Stock Recap
#PipelineProspector

Data Compilation
#PharmaFlow

07

FDA Audited

USA

FNCE 2024

Not Confirmed

FDA Audited

USA

FNCE 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

District Decision : No Action Indicated

Inspection End Date : 2012-05-29

AstraZeneca

City : Sodertalje

State :

Country/Area : SE

Zip :

District : ORA

Center : CDER